Stockreport

Kymera Therapeutics Announces Pricing of Upsized $602 Million Public Offering [Yahoo! Finance]

Kymera Therapeutics, Inc.  (KYMR) 
PDF WATERTOWN, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral sm [Read more]